Detection of doping with rhGH: Excretion study with WADA-approved kits

Drug Testing and Analysis

Volumn 3, Issue 11-12, 2011, Pages 784-790

  Jing, Jing ^a   Yang, Sheng ^a   Zhou, Xinmiao ^a,b   He, Chunji ^a   Zhang, Lisi ^a   Xu, Youxuan ^a   Xie, Minhao ^b   Yan, Yi ^b   Su, Hao ^b   Wu, Moutian ^a  

^a China Anti Doping Agency   (China)

^b BEIJING SPORT UNIVERSITY   (China)

Author keywords

Anti doping analysis; Differential immunoassay; Excretion study; Growth hormone; Isomers

Indexed keywords

BLOOD; POPULATION STATISTICS;

ANTI-DOPING ANALYSE; BLOOD SAMPLES; BODY WEIGHT; DIFFERENTIAL IMMUNOASSAY; DOPING ANALYSIS; EXCRETION STUDY; GROWTH HORMONES; HUMAN GROWTH HORMONE; SWITZERLAND; WORLD ANTI-DOPING AGENCY;

ISOMERS;

GENHEAL; HUMAN GROWTH HORMONE; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPING; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EXCRETION; EUKARYOTIC CELL; FEMALE; HUMAN; LIMIT OF DETECTION; MALE; PRIORITY JOURNAL; PROKARYOTIC CELL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 84855209288     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.359     Document Type: Article

References (20)

1. R. I. G. Holt Detection growth hormone abuse in athletes. Anal. Bioanal. Chem. 2011, DOI: 10.1007/s00216-011-5068-2
2. C. He, M. Wu Detection of doping with recombinant human growth hormone. Bioanalysis 2009, 1, 953.
3. J. Segura, R. Gutiérrez-Gallego, R. Ventura, J. A. Pascual, J. Bosch, G. Such-Sanmartin, Z. Nikolovski, A. Pinyot, S. Pchini Growth hormone in sport: Beyond Beijing. 2008. Ther. Drug Monit. 2009, 31, 3.
4. M. Bidlingmaier, C. J. Strasburger Growth hormone. Handb. Exp. Pharmacol. 2010, 195, 187.
5. C. Fredolini, D. Tamburro, G. Gambara, B. Lepene, V. Espina, E. Petricoin 111, L. A. Lotta, A. Luchini Nanoparticle technology: Amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. Drug Test Analysis 2010, 1, 447.
6. M. Okano, M. Sato, A. Ikekita, S. Kageyama Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/ electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 2046.
7. M. Bredehöft, W. Schänzer, M. Thevis Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/ electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22, 477.
8. C. J. Mitchell, A. E. Nelson, M. J. Cowley, W. Kaplan, G. Stone, S. K. Sutton, A. Lau, C. M. Lee, K. K. Ho Detection of growth hormone doping by gene expression profiling of peripheral blood. J. Clin. Endocrinol. Metab. 2009, 94, 4703.
9. A. Paparini, F. Impagnatiello, A. Pistilli, M. Rinaldi, G. Gianfranceschi, E. Signori, A. M. Stabile, V. Fazio, M. Rende, V. Romano Spica Identification of candidate genes and expression profiles, as doping biomarkers. Ann. Ig. 2007, 19, 303 (Article in Italian).
10. M. Bidlingmaier, J. Suhr, A. Ernst, Z. Wu, A. Keller, C. J. Strasburger, A. Bergmann High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin. Chem. 2009, 55, 445.
11. I. Erotokritou-Mulligan, E. Eryl Bassett, D. A. Cowan, C. Bartlett, P. Milward, A. sartorio, P. H. Sonksen, R. I. Holt The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin. Endocrinol (Oxf). 2010, 72, 520.
12. R. I. Holt, I. Erotokritou-Mulligan, C. McHugh, E. E. Bassett, C. Bartlett, A. Fityan, J. L. Bacon, D. A. Cowan, P. H. Sonksen The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-caucasian amateur athletes. Eur. J. Endocrinol. 2010, 163, 45.
13. I. Erotokritou-Mulligan, E. E. Bassett, C. Bartlett, D. Cowan, C. McHugh, R. Seah, B. Curtis, V. Wells, K. Harrison, P. H. Sonksen, R. I. G. Holt The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 2008, 93, 2760.
14. A. E. Nelson, K. K. Ho Demographic factors influencing the GH system: Implications for the detection of GH doping in sport. Growth Horm. IGF Res. 2008, 19, 327.
15. T. V. Nguyen, A. E. Nelson, C. J. Howe, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, K. K. Ho Within-subject variability and analytic imprecision of insulin-like growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin. Chem. 2008, 54, 1268.
16. WADA. Detection of Doping with Human Growth hormone. Available at: [6 June 2011].
17. WADA. Blood sample collection. Available at: [6 June 2011].
18. WADA. Decision limits for the confirmatory quantification TD2010DL. Available at: [6 June 2011].
19. V. Popii, G. Baumann Laboratory measurement of growth hormone. Clin. Chim. Acta 2004, 350, 1.
20. E. F. De Palo, V. De Filippis, R. Gatti, P. Spinella 67 Growth hormone isoforms and segments/fragments Molecular structure and laboratory measurement. Clin. Chim. Acta 2006, 364, 67.